New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global hemostasis products market size is estimated to attain at ~5.1% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 1.73 ...
BURLINGTON, Vt., January 08, 2026--(BUSINESS WIRE)--Prolytix, a U.S.-based leader in bioanalytical and protein characterization services, announces it has acquired 60 validated assays previously owned ...
Factor VII activating protease (FSAP) is a circulating serine protease that links coagulation and innate immune responses. Synthesised mainly by the liver as an inactive zymogen, FSAP becomes ...
Serotonin reuptake inhibitors, particularly selective agents (SSRIs), are widely employed in the management of mood disorders and are increasingly recognised for their effects on blood clotting ...
In light of these concepts, current massive transfusion protocols incorporate hemostasis-directed resuscitation, or the pre-emptive administration of blood coagulation products along with packed red ...
PARIS, France—Use of a potassium ferrate hemostatic patch instead of conventional dressings following radial PCI can lead to “substantial” benefits that go beyond trimming the time to hemostasis and ...
The FDA has approved Gelfoam Plus Hemostasis Kit, a combination hemostasis product that contains Pfizer’s Gelfoam Sterile Sponge and Baxter’s Thrombin (Human) dried powder for use in controlling ...
Researchers at McGill University have developed a rapid way to engineer blood clots that stop severe bleeding and support tissue healing more effectively. Their technique, called "click clotting," ...
Named among the 250 best inventions of 2024, the Quantra Hemostasis System provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes HemoSonics’ Quantra ...
Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...
Tranexamic acid significantly enhances hemostasis, achieving success rates between 83.1% and 95.0% when applied both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results